Viewing StudyNCT03721172



Ignite Creation Date: 2024-05-06 @ 12:17 PM
Last Modification Date: 2024-10-26 @ 12:56 PM
Study NCT ID: NCT03721172
Status: COMPLETED
Last Update Posted: 2024-05-29
First Post: 2018-10-09

Brief Title: Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo an Analysis of Clinical Safety and Efficacy
Sponsor: Amgen
Organization: Amgen

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-03-11
Start Date Type: ACTUAL
Primary Completion Date: 2020-03-06
Primary Completion Date Type: ACTUAL
Completion Date: 2020-07-24
Completion Date Type: ACTUAL
First Submit Date: 2018-10-09
First Submit QC Date: October 24 2018
Study First Post Date: 2018-10-26
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2021-05-17
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2020-11-04
Disp First Submit QC Date: November 4 2020
Disp First Post Date: 2020-11-06
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2024-05-10
Last Update Post Date: 2024-05-29
Last Update Post Date Type: ACTUAL